# US 2015/0104787 A1 · Non-Replicative Transduction Particles and Transduction Particle-Based Reporter Systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104787 A1
- Document ID: US20150104787A1
- Status: Published application
- Kind: A1
- Application number: 14/550,335
- Filed: 2014-11-21
- Published: 2015-04-16
- Earliest claimed: 2013-03-13
- Assignees: GeneWeave Biosciences, Inc.
- Applicants: Geneweave Biosciences, Inc.
- Inventors: Diego Ariel Rey; Nikol DeForest; Heather Cox; Soni Shukla
- Web page: https://patentgrep.com/patent/US20150104787A1

## CPC

- C12Q 1/6897: involving reporter genes operably linked to promoters
- C12N 1/20: Bacteria; Culture media therefor
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12Q 1/14: Streptococcus; Staphylococcus
- C12Q 1/18: Testing for antimicrobial activity of a material
- C12Q 1/66: involving luciferase
- C12Y 113/12007: Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
- C12N 2795/10143: viral genome or elements thereof as genetic vector
- C12N 2795/10152: relating to complementing cells and packaging systems for producing virus or viral particles
- C12N 2795/10343: viral genome or elements thereof as genetic vector
- C12N 2795/10352: relating to complementing cells and packaging systems for producing virus or viral particles
- G01N 2333/31: from Staphylococcus (G)
- G01N 2333/90241: acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Methods and systems are provided for packaging reporter nucleic acid molecules into non-replicative transduction particles for use as reporter molecules. The non-replicative transduction particles can be constructed from viruses and use viral transduction and replication systems. The reporter nucleic acid molecules include a reporter gene, such as a reporter molecule or selectable marker, for detecting target genes or cells. Methods and systems are provided for detection of cells and target nucleic acid molecules using the non-replicative transduction particles as reporter molecules.

## Claims

### Claim 1

A bacterial cell packaging system for packaging a reporter nucleic acid molecule into a non-replicative transduction particle (NRTP) for introduction into a Staphylococcus aureus (S. aureus) cell, the packaging system comprising:
a lysogenized S. aureus bacteriophage genome lacking a functional bacteriophage gene encoding a first packaging initiation site sequence, wherein the lack of the functional bacteriophage gene prevents packaging of the bacteriophage genome into the NRTP; and
a reporter nucleic acid molecule comprising a reporter gene and a functional bacteriophage gene encoding a second packaging initiation site sequence for facilitating packaging of a replicon of the reporter nucleic acid molecule into the NRTP.

### Claim 2 (depends on 1)

The system of claim 1, wherein the reporter gene is luxAB.

### Claim 3 (depends on 1)

The system of claim 1, wherein the reporter gene is operatively linked to a constitutive promoter.

### Claim 4 (depends on 3)

The system of claim 3, wherein the constitutive promoter is a S. aureus clpB promoter.

### Claim 5 (depends on 4)

The system of claim 4, wherein the S. aureus clpB promoter comprises the sequence of SEQ ID NO: 12.

### Claim 6 (depends on 1)

The system of claim 1, wherein the second packaging initiation site sequence comprises the sequence of SEQ ID NO: 9.

### Claim 7 (depends on 1)

The system of claim 1, wherein the reporter nucleic acid molecule is a plasmid comprising at least one origin of replication.

### Claim 8 (depends on 7)

The system of claim 7, wherein the at least one origin of replication is a pT181 origin of replication.

### Claim 9 (depends on 7)

The system of claim 7, wherein the at least one origin of replication comprises the sequence of SEQ ID NO: 5.

### Claim 10 (depends on 1)

The system of claim 1, wherein the reporter nucleic acid molecule is a plasmid comprising the sequence of SEQ ID NO: 14.

### Claim 11 (depends on 1)

The system of claim 1, wherein the second packaging initiation site sequence is a φ80α small terminase (terS) gene.

### Claim 12 (depends on 1)

The system of claim 1, wherein the bacteriophage is φ80α.

### Claim 13 (depends on 1)

The system of claim 1, wherein the first and second packaging initiation site sequences are small terminase (terS) genes.

### Claim 14

A bacterial cell packaging system for packaging a reporter plasmid into a non-replicative transduction particle (NRTP) for introduction into a Staphylococcus aureus (S. aureus) cell, the packaging system comprising:
a lysogenized S. aureus φ80α bacteriophage genome lacking a functional small terminase (terS) gene encoding a first packaging initiation site sequence, wherein the lack of the functional terS gene prevents packaging of the bacteriophage genome into the NRTP; and
a reporter plasmid comprising a luxAB reporter gene operatively linked to a S. aureus clpB promoter comprising the sequence of SEQ ID NO: 12, a pT181 origin of replication comprising the sequence of SEQ ID NO: 5, and a functional φ80α terS gene encoding a second packaging initiation site sequence comprising the sequence of SEQ ID NO: 9, the second packaging initiation site sequence facilitating packaging of a replicon of the reporter nucleic acid molecule into the NRTP.

### Claim 15 (depends on 1)

A method for producing and collecting a plurality of non-replicative transduction particles (NRTPs), comprising:
providing conditions to the packaging system of claim 1 comprising (a) inducing a lytic phase of the packaging system, and (b) allowing the replicon of the reporter nucleic acid molecule to be packaged to produce the NRTPs; and
collecting a lysate comprising the plurality of NRTPs.

### Claim 16 (depends on 15)

The method of claim 15, wherein the lysate is stable at 24° C.

### Claim 17 (depends on 15)

A method for detecting a presence or an absence of Staphylococcus aureus (S. aureus) in a sample, comprising:
contacting the sample with a lys ate produced by the method of claim 15 such that the plurality of NRTPs transduces one or more S. aureus cells in the sample;
providing conditions for activation of the reporter gene; and
detecting the presence or absence of a signal produced by the reporter gene, wherein the presence of the signal indicates the presence of S. aureus, and wherein the absence of the signal indicates the absence of S. aureus.

### Claim 18 (depends on 17)

The method of claim 17, wherein the method produces at least 90% specificity of detection with reference to a Gold standard.

### Claim 19 (depends on 17)

The method of claim 17, wherein the method produces at least 90% sensitivity of detection with reference to a Gold standard.

### Claim 20 (depends on 17)

The method of claim 17, further comprising providing an antimicrobial agent to the sample and detecting for the presence or absence of a signal produced by the reporter gene to determine whether the sample contains a cell that is resistant or susceptible to the antimicrobial agent.
